Trial
NCT05700630
Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV Viremia
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
—
Condition
HIV-1-infection
Intervention
FT538
Why stopped
Abandoned
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-26